Consultant Medical Oncologist, Mount Vernon Hospital
Dr. Nathan is consultant medical oncologist at Mount Vernon Cancer Centre, Northwood, UK. His specialist interests are the treatment of malignant melanoma and renal cell carcinoma. His clinical training was through Cambridge and London having had an earlier scientific career in the pharmaceutical industry. He chairs the NCRI Renal Carcinoma Clinical Studies Group, chaired the development of UK guidelines for the management of uveal melanoma and is co-author of the UK cutaneous melanoma guidelines. He leads a number of academic studies on the national portfolio. He is chief investigator of SELPAC, a uveal melanoma study, is co-CI of PERM which is investigating the abscopal effect induced by radiotherapy in melanoma patients receiving pembrolizumab, and leads the national Merkel cell study UKMCC-1. He is UK chief investigator and steering committee member for a number of pharma sponsored melanoma studies. He is a trustee of the charity Melanoma Focus and is contributing to the initiative to develop a UK national melanoma database.